Poplar Therapeutics
Cambridge
About Poplar Therapeutics
Poplar Therapeutics anti-IgE therapy treats atopic diseases such as food allergy, allergic asthma, and atopic dermatitis.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $50.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2026)
- Website: poplartx.com
Industries & Categories
Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/poplar-therapeutics-56406 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.